Australia's GenesisCare bags fresh capital from return backer KKR, others

Australia's GenesisCare bags fresh capital from return backer KKR, others

A research technologist prepares a Tessa Therapeutics Pte. virus specific t-cells (VST) infusion for cancer patients as part of a clinical trial inside a good manufacturing practice (GMP) room at Singapore's National Cancer Center (NCCS) in Singapore, on Thursday, Feb 23, 2017. Photographer: Nicky Loh/Bloomberg

Sydney-headquartered cancer and cardiac care company GenesisCare has announced that it has raised an undisclosed sum from a number of investors, including KKR and China Resources.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter